Butyrate-producing bacteria as pharmabiotics for inflammatory bowel disease

Probiotics in the Management of Inflammatory Bowel Disease

(2012) Daisy Jonkers et al.   DRUGS

Butyricicoccus pullicaecorumin inflammatory bowel disease

(2012) Venessa Eeckhaut et al.   GUT

The gut anaerobe Faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic–anoxic interphases

(2012) M Tanweer Khan et al.   ISME Journal

Perturbation Dynamics of the Rumen Microbiota in Response to Exogenous Butyrate

(2012) Robert W. Li et al.   PLoS One

The function of our microbiota: who is out there and what do they do?

(2012) Noora Ottman et al.   Frontiers in Cellular and Infection Microbiology

Cultured Representatives of Two Major Phylogroups of Human Colonic Faecalibacterium prausnitzii Can Utilize Pectin, Uronic Acids, and Host-Derived Substrates for Growth

(2011) Mireia Lopez-Siles et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Rates of production and utilization of lactate by microbial communities from the human colon

(2011) Alvaro Belenguer et al.   FEMS MICROBIOLOGY ECOLOGY

Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes

(2010) P. Veiga et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene

(2009) Petra Louis et al.   ENVIRONMENTAL MICROBIOLOGY

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

(2008) H. Sokol et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA